GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
7PY4 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited state | |
8OX8 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited "open" conformation | |
8OX8 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited "open" conformation | |
8OX7 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited "closed" conformation | |
8OX7 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited "closed" conformation | |
8OX9 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2P active conformation with bound PC | |
8OX9 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2P active conformation with bound PC | |
8OXA | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PS | |
8OXA | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PS | |
8OXC | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PI | |
8OXC | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PI | |
8OXB | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PC | |
8OXB | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PC | |
8OX5 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E1P-ADP conformation | |
8OX5 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E1P-ADP conformation | |
8OX6 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E1P conformation | |
8OX6 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E1P conformation | |
8OX4 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E1-ATP conformation | |
8OX4 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E1-ATP conformation | |
7N78 | Q9NQ11 | Cryo-EM structure of ATP13A2 in the E2-Pi state | |
7N70 | Q9NQ11 | Cryo-EM structure of ATP13A2 in the BeF-bound E2P-like state | |
7N72 | Q9NQ11 | Cryo-EM structure of ATP13A2 in the AlF-bound E2-Pi-like state | |
7JHH | Q13131 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
7JHH | O43741 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
7JHH | P54619 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
7JHH | 7JHH | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
7JHH | C3SHQ8 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
7JHG | Q13131 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
7JHG | O43741 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
7JHG | P54619 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
7JHG | 7JHG | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
7JHG | C3SHQ8 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
7W02 | Q99758 | Cryo-EM structure of ATP-bound ABCA3 | |
6NP0 | E9QLC0 | Cryo-EM structure of 5HT3A receptor in presence of granisetron | 5-hydroxytryptamine receptor 3A |
6W1Y | Q8K1F4 | Cryo-EM structure of 5HT3A receptor in presence of Palonosetron | 5-hydroxytryptamine receptor 3A |
6W1M | Q8K1F4 | Cryo-EM structure of 5HT3A receptor in presence of Ondansetron | 5-hydroxytryptamine receptor 3A |
6W1J | Q8K1F4 | Cryo-EM structure of 5HT3A receptor in presence of Alosetron | 5-hydroxytryptamine receptor 3A |
7MO7 | P14210 | Cryo-EM structure of 2:2 c-MET/HGF holo-complex | |
7MO7 | P08581 | Cryo-EM structure of 2:2 c-MET/HGF holo-complex | |
7LY9 | 7LY9 | Cryo-EM structure of 2909 Fab in complex with 3BNC117 Fab and CAP256.wk34.c80 SOSIP.RnS2 N160K HIV-1 Env trimer | |
7LY9 | A0A0N9FF17 | Cryo-EM structure of 2909 Fab in complex with 3BNC117 Fab and CAP256.wk34.c80 SOSIP.RnS2 N160K HIV-1 Env trimer | |
7MO8 | P14210 | Cryo-EM structure of 1:1 c-MET I/HGF I complex after focused 3D refinement of holo-complex | |
7MO8 | P08581 | Cryo-EM structure of 1:1 c-MET I/HGF I complex after focused 3D refinement of holo-complex | |
8B7Q | P41160 | Cryo-EM structure for the mouse LEPR-CRH2:Leptin:LEPR-Ig complex following symmetry expansion in combination with local refinement | |
8B7Q | P48356 | Cryo-EM structure for the mouse LEPR-CRH2:Leptin:LEPR-Ig complex following symmetry expansion in combination with local refinement | |
6CUF | Q2N0S6 | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6CUF | 6CUF | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6CUF | Q2N0S7 | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6N1W | Q2N0S6 | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain |
6N1W | 6N1W | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024